This Pennsylvania House Resolution designates June 23, 2026, as Dravet Syndrome Awareness Day to highlight a rare genetic form of epilepsy that affects approximately 20,000 people in the United States. The bill does not change laws or allocate funding but serves to raise public awareness about the condition, which often begins in infancy with temperature-sensitive seizures and can lead to developmental delays. By recognizing this specific date, the resolution aims to honor medical professionals and families impacted by the disease while acknowledging the importance of early diagnosis and comprehensive care.
This bill is a ceremonial resolution that designates the week of September 12 through 18, 2026, as "Neonatal Nurses Week" in Pennsylvania. It aims to honor the work of neonatal nurses who provide specialized care to newborn infants, particularly those in intensive care units with complex health needs. The measure does not change any laws or policies but serves to publicly acknowledge the skills and dedication of these healthcare professionals.
This resolution formally recognizes August 2026 as "National Breastfeeding Month" within the state of Pennsylvania. It serves as a symbolic gesture to raise awareness about the health benefits of breastfeeding for infants and mothers, citing recommendations from major medical organizations. The text does not alter any laws or create new programs, but rather acknowledges existing state protections and insurance coverage related to lactation support.
This Pennsylvania House Resolution designates the week of September 14 through 20, 2026, as "Birth Center Week" to highlight the role of birth centers in maternal healthcare. The measure aims to raise public awareness about these facilities, which offer low-risk, culturally competent care in a home-like setting and are noted for potentially lower costs and reduced cesarean section rates. While the resolution does not alter laws or funding, it formally acknowledges the value of birth centers in addressing maternal health disparities and improving access to care for mothers and newborns.
This House resolution designates June 27, 2026, as PTSD Awareness Day in Pennsylvania to highlight the mental health condition caused by traumatic events. The measure aims to increase public understanding of PTSD symptoms and reduce the stigma surrounding the disorder among all residents, including veterans and first responders. By officially recognizing this date, the bill encourages discussions about available treatments and the importance of seeking help.
This Pennsylvania House Resolution designates September 2026 as Prostate Cancer Awareness Month to highlight the importance of early detection and screening for men. The bill includes background information on prostate cancer statistics, symptoms, and recommended screening ages based on risk factors, but it does not create new laws or require specific actions from individuals or organizations. Its primary effect is symbolic, aiming to raise public awareness rather than implementing concrete policy changes or funding programs.
This Pennsylvania bill requires most health insurance plans to cover vaginal estrogen when used to treat menopausal symptoms or prevent urinary tract infections. The law mandates that insurers include FDA-approved drugs, devices, and combination products for this treatment, though they may still apply standard rules regarding medical necessity and patient cost-sharing. Coverage applies to new or renewed policies starting 90 days after the bill takes effect, with specific timelines for plans that do not need to file rates or forms with the state.
HB 1244 requires health insurance policies and government health programs in Pennsylvania to cover pelvic floor therapy and related treatments for pelvic floor dysfunction. This includes services like biofeedback, trigger point therapy, electrical stimulation, and postoperative care for prostatectomies, hysterectomies, and postpartum assessments. The coverage applies to policies issued or renewed after the bill's effective date, though insurers may still apply medical necessity standards and cost-sharing requirements. The bill directly affects all health insurance companies and government health programs (such as Medicaid) operating under Pennsylvania's insurance law.
This bill requires Medicaid programs and private health insurance plans to cover bone density screenings, preventive care, and treatments for osteoporosis specifically linked to menopause. It directly affects postmenopausal women, particularly those with low income who rely on Medicaid, by ensuring access to these services without cost barriers. The key provision mandates that both public medical assistance programs and private insurers include these osteoporosis-related services in standard coverage. This expands existing coverage to explicitly address menopause-related bone health needs.
HB 1346 amends Pennsylvania's Insurance Company Law to mandate coverage for menopause treatments in health insurance policies. This bill requires health insurance policies offered or renewed in the Commonwealth to provide coverage for both hormonal and non-hormonal treatments for menopausal symptoms. The required coverage includes FDA-approved drugs, devices, behavioral therapy, and treatments for menopause induced by a hysterectomy. This ensures individuals in Pennsylvania experiencing menopause or related symptoms have access to covered treatments, subject to the standard terms and conditions of their health insurance policy.